Literature DB >> 8691515

Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms.

N Sakalihasan1, P Delvenne, B V Nusgens, R Limet, C M Lapière.   

Abstract

PURPOSE: This consistent observation of a reduction of the elastin concentration in abdominal aortic aneurysms (AAAs) has led us to investigate in AAA specimens two metalloproteinases that display elastase activity, MMP2 (gelatinase A/72kDa) and MMP9 (gelatinase B/92 kDa).
METHODS: Samples of full-thickness aortic wall, adherent thrombus, and serum were collected in 10 patients with AAAs. Samples of normal aortic wall and serum were taken from 6 age-matched control patients. Quantitative gelatin-zymography and gelatinolytic soluble assays after acetyl-phenyl mercuric acid activation were performed on serum and tissue extracts, and the results were expressed in units on a comparative wet-weight basis. Histologic analysis was performed in parallel to score the inflammatory infiltrate.
RESULTS: The luminal and parietal parts of the thrombus contained, respectively, 20- and 10-fold more gelantinolytic activity than the serum. The predominate form was MMP9. Although the total gelatinolytic activity was in the same range both in AAAs and in normal walls, a significantly higher proportion of MMP9 was found in the aneurysmal aortic walls. Furthermore, a significant proportion of MMP9 was under its processed active form, which was never observed in normal samples. A significantly higher proportion of MMP2 was also present as processed active form in AAA wall. This latter parameter positively correlated with the inflammatory score.
CONCLUSIONS: The presence of activated MMP9 and MMP2 might contribute to the degradation of the extracellular matrix proteins that occurs during the development of aneurysms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691515     DOI: 10.1016/s0741-5214(96)70153-2

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  67 in total

1.  Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model.

Authors:  Paul D DiMusto; Guanyi Lu; Abhijit Ghosh; Karen J Roelofs; Gang Su; Yunge Zhao; Christine L Lau; Omar Sadiq; Brendan McEvoy; Adriana Laser; Jose A Diaz; Thomas W Wakefield; Peter K Henke; Jonathan L Eliason; Gilbert R Upchurch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 3.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 4.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 5.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

6.  Temporal regulation of venous extracellular matrix components during arteriovenous fistula maturation.

Authors:  Michael R Hall; Kota Yamamoto; Clinton D Protack; Masayuki Tsuneki; Go Kuwahara; Roland Assi; Kirstyn E Brownson; Hualong Bai; Joseph A Madri; Alan Dardik
Journal:  J Vasc Access       Date:  2014-09-08       Impact factor: 2.283

Review 7.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

8.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.

Authors:  Vincent Fontaine; Marie-Paule Jacob; Xavier Houard; Patrick Rossignol; Didier Plissonnier; Eduardo Angles-Cano; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

9.  On the potential increase of the oxidative stress status in patients with abdominal aortic aneurysm.

Authors:  J Pincemail; J O Defraigne; J P Cheramy-Bien; N Dardenne; A F Donneau; A Albert; N Labropoulos; N Sakalihasan
Journal:  Redox Rep       Date:  2012-06-21       Impact factor: 4.412

10.  LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Regulates Smooth Muscle Contractility by Modulating Ca2+ Signaling and Expression of Cytoskeleton-Related Proteins.

Authors:  Dianaly T Au; Zhekang Ying; Erick O Hernández-Ochoa; William E Fondrie; Brian Hampton; Mary Migliorini; Rebeca Galisteo; Martin F Schneider; Alan Daugherty; Debra L Rateri; Dudley K Strickland; Selen C Muratoglu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.